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ABSTRACT 
Background 
 
Chronic pancreatitis is a progressive inflammatory disorder characterized by 
irreversible destruction of pancreatic parenchyma and may be associated with 
disabling chronic pain and permanent loss of endocrine and exocrine function. Main 
indication for surgery is intractable abdominal pain and choosing the best technique to 
be used for a patient remains a challenge. 
 
Objectives 
The study is intended to know the etiology, incidence, pathogenesis, clinical 
manifestation and the outcome of the following three methods of surgical 
management  chronic pancreatitis namely,  
1.FREY’S PROCEDURE, 
2.PUESTOW GILLESBY PROCEDURE & 
3.IZBICKE’S PROCEDURE. 
Also to study complications of these procedures and recurrences if any. 
Method 
This is a prospective cross sectional  study, where 32 patients admitted to our 
hospital with chronic calcifying pancreatitis, who met with the inclusion and exclusion 
criteria, were subjected to clinical examination and relevant investigations. The 
treatment is carried out depending upon the  magnitude of disease, size of the main 
pancreatic duct, parenchymal calcification and patient’s predominant symptom. The 
results are evaluated and analyzed by comparing with other previous standard results. 
 
 
Results 
 A male preponderance noted to be about 30:2 in this study. Mean age of 
presentation was noticed to be in the range of thirty to forty years. This disease was 
found to be more prevalent in persons who are chronic alcoholic. 
Clinically patients presented with chronic abdominal  pain with diabetes 
mellitus and malabsorbtion due to endocrine & exocrine insufficiency. All the patients 
had  radiological abnormalities. The complications noted were wound infection, 
wound dehiscence & postoperative persistent pain.On comparing with post operative 
pain relief,improvement of exocrine & endocrine function of pancreas,improvement 
of performance status of the patient among the three surgical procedures compared 
FREY’S PROCEDURE is the more effective  comparing to other two procedures. 
 
Conclusion 
In this study it is found that  the most common etiology for chronic pancreatitis 
was chronic  alcoholism in the middle aged   male . chronic pancreatitis  is mainly a 
radiological diagnosis. Of the various treatment modalities available for the treatment 
of this disease Frey’s  procedure has lower complication rates, better pain relief, 
improvement of  exocrine and endocrine functions and overall  improvement in 
quality of life. 
  
Key words  
Chronic calcifying pancreatitis, resection and drainage procedures, FREY’S 
PROCEDURE,PUESTOW GILLESBY PROCEDURE & IZBICKE’S 
PROCEDURE, Complications, Recurrence, Anastomosis.  
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INTRODUCTION 
Chronic pancreatitis  is a progressive inflammatory process of the 
pancreas leading eventually  over several years to pancreatic “cirrhosis”. 
Chronic pancreatitis  Clinically, is usually characterised by an initial stage of 
recurrent acute pancreatitis (early stage CP) and progressive pancreatic 
dysfunction and/or calcification (late-stage CP). Alcohol abuse is the prominent 
risk factor of CP (70%), while CP remains aetiologically undetermined in about 
25% or is related to rare causes such as genetic mutations, 
hyperparathyroidism, trauma or “autoimmunity”4. 
Surgery is frequently indicated for  relief of debilitating pain as well as 
to address other complications, and three operations have proven effective. The 
pancreatico-duodenectomy (Whipple) procedure results in excellent long-term 
pain relief,but is associated with a low mortality rate and a persistent risk of 
early and late complications. The duodenum-preserving pancreatic head 
resection (DPPHR) introduced by Beger et al, and the local resection of the 
pancreatic head with longitudinal pancreatico-jejunostomy (LR-LPJ) devised 
by Frey,achieve the same high rate of pain relief long term but are associated 
with lower rates of perioperative complications and a decreased incidence of 
diabetes long term.9 All 3 operations address the head of the pancreas as the 
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nidus of persistent inflammation, and all 3 achieve success with both dilated 
and nondilated duct disease. The LR-LPJ has a lower risk of perioperative 
problems and may be easier to perform. 
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OBJECTIVES OF STUDY 
1)  To compare the following techniques in the management of chronic 
pancreatitis 
1. FREY’S PROCEDURE 
2. PUESTOW GILLESBY PROCEDURE & 
3.  IZBICKE’S PROCEDURE. 
 
2) To study the rate of success of these three procedures in the 
management of chronic pancreatitis  and its complications, recurrences 
if any. 
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REVIEW OF LITERATURE 
 
Historical aspects 
Operative approaches to the treatment of chronic pancreatitis have 
undergone  dramatic a transformation over the past few decades as the head of 
the pancreas has become universally appreciated  as the nidus of chronic 
inflammation12.Furthermore prospective randomized trials have repeatedly 
shown the superiority of surgical treatment over medical approaches to 
management. Since the publication of the definitive “History of the Pancreas” 
by Howard and Hess in 2002 as well as other recent reviews, new information 
and the results of prospective trials have further clarified the value of the latest 
“hybrid” approaches to the treatment of this disease.16 
Relevant Anatomy 
The pancreas is a soft, elongated, flattened gland 12 to 20 cm in length. 
The adult gland weighs between 70 and 110 g. The head lies behind the 
peritoneum of the posterior abdominal wall and has a lobular structure. The 
pancreas is covered with a fine connective tissue but does not have a true 
capsule. The head of the pancreas is on the right side and lies within the 
curvature of the duodenum. The neck, body, and tail of the pancreas lie 
obliquely in the posterior abdomen, with the tail extending as far as the gastric 
surface of the spleen.  
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( Fig. 53-1 ). 
 The duct of Wirsung is the main pancreatic duct extending from the tail 
of the organ to the major duodenal papilla, or ampulla of Vater. The widest part 
of the duct is in the head of the pancreas (4 mm), tapering to 2 mm at the tail in 
adults. The duct of Wirsung is close, and almost parallel, to the distal common 
bile duct before combining to form a common duct channel prior to 
approaching the duodenum. In approximately 70% of people, an accessory 
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pancreatic duct of Santorini (dorsal pancreatic duct) is present. This duct may 
communicate with the main pancreatic duct. The degree of communication of 
the dorsal and ventral duct varies from patient to patient. 
 
Figure 5. A, Anatomy of the major and minor papilla; B, sphincter of Oddi; C, 
endoscopic view. 
 
Figure 6. Regions of the pancreas 
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Incidence 
In 1998, Lankisch and Banks reported that the prevalence of chronic 
pancreatitis in many parts of the world appeared to be in the range of 3–10 per 
100,000 people . Most cases of chronic pancreatitis require hospitalization due 
to the presence of pain as well as to the appearance of other complications. In 
Italy, according to the data reported by the Department of the Welfare in 2005 
[7], the rate of patients discharged for chronic pancreatitis is 32.9 per 100,000 
hospitalized patients (Figure 1). The age of the major part of these patients 
ranges from 45 to 64 years (Figure 1) and the majority are males (Figure 2). 
The mean length of hospitalization is 9.8 days and this figure is higher as 
compared to that of all patients with diseases other than chronic pancreatitis 
(7.5 days). Finally, in Italy the trend of hospitalization for chronic pancreatitis 
seems to have decreased from 1999 to 2005 (Figure 3). There is no doubt that, 
in Western countries, alcohol is the most frequently associated factor of chronic 
pancreatitis, chronic alcoholic pancreatitis presents mainly in young adults of 
30–40 years of age, and the prevalence is higher in the male gender. In these 
countries, in the period from 1940 to 2003, alcohol frequency increased as an 
etiological factor of chronic pancreatitis from 19 [8] to 50% [9] and even up to 
80% [10-12]. The results of the latter study regarding the etiology of chronic 
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pancreatitis were subsequently confirmed by others in Europe [13-19] as well 
as in Brazil [20], Australia [21] and South Africa [22]. On the other hand, four 
consecutive surveys carried out in Japan (from 1970 to 1977, from 1977 to 
1984, in 1994, and in 1999, respectively) [23] showed that alcohol as an 
etiological factor accounted for less than 60% and this figure is similar among 
the various periods studied. 
Aetiology  
 
Alcohol 
The most common cause of chronic pancreatitis in Western societies is 
alcohol. Alcohol consumption has been implicated in approximately 70% of 
cases as a major cause of this disease.19 Developing between 30 and 40 years of 
age, this chronic pancreatitis is more common in men than in women. A direct 
relationship existsbetween the daily consumption of alcohol and the risk of 
development of chronic pancreatitis. Although the length of time required to 
produce symptoms is unknown,there is clearly a correlation between the 
quantity and duration of alcohol consumption and the risk of developing 
chronic pancreatitis. It is estimated that alcohol intake greater than 20g per day 
over a period of 6–12 years produces changes consistent with chronic 
pancreatitis. There are several theories regarding the mechanism by which 
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alcohol produces chronic pancreatitis; however, the exact mechanism is 
unknown. 
Pancreas Divisum 
The most common congenital anomaly of the pancreas, pancreas 
divisum, occurs in approximately 10% of the population and results from 
incomplete or absent fusion of the dorsal and ventral ducts during 
embryological development. In pancreas ivisum, the ventral duct of Wirsung 
empties into the duodenum through the major papilla, but drains only a small 
portion of the pancreas (ventral portion). Other regions of the pancreas, 
including the tail, body, neck, and the remainder of the head, drain secretions 
into the duodenum through the minor papilla via the dorsal duct of Santorini 
(hence the term dominant dorsal duct syndrome) (Figure 8). 
Recent clinical trials have supported the concept that obstruction of the 
minor papilla may cause acute pancreatitis or chronic pancreatitis in a subgroup 
of patients with pancreas divisum. Endoscopic or surgical therapy directed to 
the minor papilla has been effective in treating these patients. 
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Figure 8. Anatomy of pancreas divisum. 
Tropical Pancreatitis 
Tropical pancreatitis is found predominantly throughout Asia, Africa 
and other tropical locales. Men and women are affected with equal frequency 
without any known etiological factors. Young people (mean age at onset, 12–
15 years) may be affected. Although the etiology is speculative, malnutrition 
may play an important role in its pathogenesis. Patients usually develop 
recurrent abdominal pain in childhood and diabetes mellitus later in life.24 
Pancreatic stone formation is present in the majority of these patients. 
Hyperparathyroidism 
Chronic pancreatitis occurs in untreated hyperparathyroidism. 
Hypercalcemia is thought to be the mechanism by which hyperparathyroidism 
causes chronic pancreatitis. Hypercalcemia causes an increase in calcium 
secretion by the pancreas. In the animal model, hypercalcemia causes 
11 
 
stimulation of the acinar cell, increases calcium secretion, and alters the 
diffusion barrier between the pancreatic duct lumen and the interstitial space. 
Trauma 
Trauma to the back or abdomen may produce pancreatic injury (Figure 
9A) leading to chronic pancreatitis. Trauma may result in inflammation and the 
formation of pseudocysts or strictures (Figure 9B). Many cases of pancreatic 
injury are associated with ductal disruption.34 
 
Figure 9. A, B, Pancreatic injury from trauma. 
Obstructive pancreatitis 
Chronic pancreatitis is also associated with obstruction of the pancreatic 
duct secondary to strictures related to pancreatic inflammation, or benign or 
malignant tumors. Sphincter of Oddi dysfunction involving the pancreatic or 
ampullary sphincter of the duct is thought to be another cause. Pathological 
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findings in this type of pancreatitis include the absence of intraductal calculi or 
plugs, and uniform dilation of the duct distal to the obstruction site. 
Idiopathic Chronic Pancreatitis 
Idiopathic chronic pancreatitis is the major form of nonalcoholic disease 
in Europe and North America, occurring in 10–40% of those with chronic 
pancreatitis. This form of pancreatitis affects juveniles, with an onset of 
symptoms at a median age of 18. The senile type appears to peak at 60 years of 
age. Arteriosclerosis has been suggested as a cause of senile chronic 
pancreatitis, although firm evidence implicating vascular insufficiency is 
lacking. 
Cystic Fibrosis 
There is an association between patients with pancreatitis and mutation 
of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. In 
this subset of patients, there is no evidence of cystic fibrosis lung disease. It is 
possible that some patients who carry the diagnosis of idiopathic pancreatitis 
may well have pancreatitis as a result of this genetic mutation.44 
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Hereditary Chronic Pancreatitis 
Hereditary chronic pancreatitis appears in childhood at a mean age of 
10–12 years. This form of pancreatitis affects familial groups and involves a 
small number of related individuals. Hereditary chronic pancreatitis is 
transmitted through an autosomal dominant gene of incomplete penetrance, and 
the incidence is relatively equal in both sexes. The majority of these patients 
express one of two mutations (which are R122H or N29I) in the cationic 
trypsinogen gene (PRSS1 gene). This defect prevents deactivation of 
trypsinogen resulting in autodigestion. Hereditary chronic pancreatitis is 
characterized by recurrent attacks of abdominal pain.44 Diabetes develops in 
approximately 20% of these patients 8–10 years after the onset of pain. 
Hereditary chronic pancreatitis has about a 40% lifetime risk of pancreatic 
cancer with patients in the fifth to seventh decades of life having the highest 
risk. 
Pathogenesis of Alcoholic Pancreatitis 
  
The mechanism which determines the main manifestation of chronic 
pancreatitis, i.e., fibrosis of the pancreatic gland, has been well summarized by 
Taludkar et al. [40]. In brief, the oxidation of ethanol to acetaldehyde 
determines the activation of the pancreatic stellate cells in the quiescent state 
without any pre-activation; this process generates a state of oxidant stress 
14 
 
within the pancreatic stellate cells which subsequently activates the 
downstream pathways of the fibrogenesis. This finding implies that, in the 
human pancreas, pancreatic stellate cells may be stimulated early during 
chronic alcohol intake even in the absence of necro-inflammation.  
The importance of the oxidative stress in chronic pancreatitis patients 
has also been reported using breath analysis [41]. In this study, H2S, NO and a 
substance having a molecular mass of 66 u (M66) were those which had 
significantly higher breath concentrations in chronic pancreatitis patients than 
in healthy subjects after adjustment for the significant differences in H2S, M66, 
and NO were found between patients with and without alcoholic pancreatitis.  
Regarding the pancreatic stellate cells, in 1982, Watari et al. [42] 
reported the presence of vitamin A-containing cells in the vitamin A-fed rat 
pancreas. These were later described and characterized as stellate cells in the 
rat and the human pancreas [43,44]. Pancreatic stellate cells are 
morphologically similar to hepatic stellate cells. They have long cytoplasmic 
processes and are situated close to the pancreatic acini. 
 In the quiescent state, these cells contain lipid droplets, store vitamin A 
and express markers such as desmin, glial fibrillary acidic protein, neural cell 
adhesion molecule and neurotrophin nerve growth factor just as hepatic stellate 
cells do. Pancreatic stellate cells contain enzyme alcohol dehydrogenase [45] 
and, when activated, they assume a myofibroblast-like phenotype [46]. 
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Activated pancreatic stellate cells are characterized by the disappearance of fat 
globules and the expression of alpha-smooth muscle actin. These cells have 
proliferative and migratory [47-49] functions, and they also synthesize and 
secrete extracellular fibrous tissue matrix proteins, matrix metalloproteinases 
and their inhibitors [50]; it has also been demonstrated that pancreatic stellate 
cells have phagocytic activity [51]. Thus, the ability of pancreatic stellate cells 
to synthesize as well as to degrade extracellular matrix proteins suggests their 
role in maintaining a normal pancreatic architecture which can shift towards 
fibrogenesis if the balance is altered. Ethanol, acetaldehyde and oxidant stress 
are capable of activating pancreatic stellate cells via three mitogen-activated 
protein kinase pathways [52], namely extracellular signal kinase, p38 kinase 
and c-jun amino terminal kinase [53-55], and ethanol and acetaldehyde are also 
capable of activating phosphatidylinositol 3-kinase and protein kinase C [56]. 
On the other hand, extracellular signal kinase activation occurs via a signal 
transduction pathway which involves G-protein Ras and serine threonine 
protein kinase Raf-1 [57,58]. The Ras superfamily G proteins undergo post-
translational modification involving isoprenylation, a process which requires 
intermediate substrates of cholesterol biosynthesis [59,60] which is regulated 
by HMG CoA reductase [61]. The paracrine pro-fibrogenic effect of TGF-beta 
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on pancreatic stellate cells is mediated via Smad while the autocrine effect is 
mediated through the extracellular signal kinase pathway [62]; furthermore, the 
role of the peroxisome proliferator-activated receptor-gamma seems to be 
involved in the activation of pancreatic stellate cells [63,64].  
The major parts of the studies published on pancreatic stellate cells have 
been carried out on experimental animals; thus, the study of Suda et al. seems 
to be of particular interest because it was carried out on humans [65]. These 
authors investigated the distribution of activated pancreatic stellate cells or 
myofibroblasts using immunohistochemistry and a computer-counting device 
in relation to fibrogenesis in 24 patients with clinically diagnosed chronic 
alcoholic pancreatitis. In all cases, fibrosis was patchily distributed in the 
perilobular or interlobular areas accompanied by a cirrhosis-like appearance; it 
had extended into the intralobular area in advanced cases. Seven patients had a 
massive or confluent loss of exocrine tissue, resulting in extensive interlobular 
fibrosis; the more extensive the interlobular fibrosis, the smaller the lobules. 
Immunoreactivity to alpha-smooth muscle actin, a myofibroblast marker, was 
found mostly in the same areas of the fibrosis, mainly the interlobular and less 
often the periacinar, areas; the average percentage area of perilobular 
myofibroblasts was significantly higher than that of periacinar myofibroblasts 
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in 20 randomly selected lobules; the fibrosis also immunostained positive for 
collagen types I and III. In conclusion, this study, carried out on Int. J. Environ. 
Res. Public Health 2009, 6 2770  humans, further supports the hypothesis that 
the fibrotic alterations in chronic alcoholic pancreatitis are not due to recurrent 
episodes of necrotizing pancreatitis but the disease is due to a chronic 
stimulation of alcohol on pancreatic stellate cells which play an important role 
in pancreatic fibrogenesis.  
Histology of Alcoholic Pancreatitis  
According to the previously described pathogenesis, alcohol seems to 
induce pancreatic fibrosis (Figure 4) as it has frequently been found in autoptic 
series of alcoholics without a clinical history of chronic pancreatitis [66-68]. 
Two histological studies [69,70] were conducted on the pancreata of patients at 
the time of their first attack of acute alcoholic pancreatitis, and both studies 
found the presence of chronic lesions in the acutely inflamed pancreas. 
Moreover, in a clinical study [71] of 114 patients hospitalized for acute 
alcoholic pancreatitis as the first manifestation of pancreatic disease, a 
diagnosis of chronic pancreatitis was made in 105 (92%) of the 114 patients 
during the follow-up. These authors concluded that acute alcoholic pancreatitis 
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without underlying chronic pancreatitis does not exist or is extremely rare. 
 
Figure 4. Typical pathological appearance of human chronic 
pancreatitis: Fibrosis, loss of acinar tissue, enlarged ducts and stones within 
some of them.  
Based on the data of the literature and on our experience, we believe that 
the great majority (>90%) of alcoholic patients who present clinically with 
acute pancreatitis also have chronic lesions. The possibility that an alcoholic 
with acute pancreatitis has no chronic pancreatic lesions certainly cannot be 
excluded but, if this condition exists, it is rare [72].  
A working hypothesis called-fibrosis sequence‘ has been also suggested 
for explaining the pathogenesis 
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Symptoms 
The clinical presentation of chronic pancreatitis is usually abdominal 
pain, ranging from a sudden acute abdominal catastrophe to mild episodes of 
deep epigastric pain and possible vomiting. Chronic pancreatitis may produce 
constant, dull, unremitting abdominal pain, epigastric tenderness, weight loss, 
steatorrhea and glucose intolerance. Diarrhea may be chronic, with as many as 
six or more bowel movements per day. The diarrhea is caused by fat 
malabsorption, which results in bulky, foul-smelling stools that may appear 
oily and float (steatorrhea). With the head of the gland on the right side, lying 
within the curve of the duodenum at the second lumbar vertebra (L2) level of 
the spine (Figure 3), the pain of chronic pancreatitis often radiates to the 
back,although it may radiate to both upper and lower quadrants. Sitting up and 
leaning forward  may help to relieve or reduce the discomfort. 
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Typical posture to reduce pancreatic-type pain. 
DiagnosisOver the years, numerous tests have been developed to 
diagnose chronic pancreatitis; however, their sensitivity and specificity are 
poor. To date, historical information, serum enzymes, exocrine function, and 
radiographic studies seem to be the most reliable indicators of the disease. 
Biochemical measurements of pancreatic function are helpful. 
Biochemical Measurements 
Isoamylase, lipase, trypsin, and elastase levels may be low, normal, or 
elevated in patients with chronic pancreatitis. In early or mild cases of chronic 
pancreatitis, it is difficult to make a definitive diagnosis based on serum 
enzyme levels alone.The secretin stimulation test is the most sensitive test to 
diagnose early pancreatic disease in patients who have developed 
malabsorption problems.The bentiromide test is inexpensive, convenient, and 
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easily available for diagnosis of advanced disease. This test, however, has a 
low sensitivity for diagnosing early or mild chronic pancreatitis. Essentially a 
urine test, it requires normal renal function, adequate diuresis, and proper 
absorption in the intestines. Para-aminobenzoic acid (PABA) is the result of the 
synthetic tripeptide bentiromide, cleaved by pancreatic chymotrypsin, in the 
duodenum and excreted in the urine (Figure 10A). Patients consistently excrete 
less PABA with chronic pancreatitis because of impaired chymotrypsin 
secretion by the pancreas (Figure 10B). 
 
Bentiromide test; A, para-aminobenzoic acid (PABA) excreted in urine; B, 
chronicpancreatitis — little or no PABA in the urine. 
 
Figure 10. Bentiromide test; A, para-aminobenzoic acid (PABA) 
excreted in urine; B, chronic pancreatitis — little or no PABA in the urine. 
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The quantitative measurement of fecal fat is diagnostic in determining 
malabsorption. In this test, a known quantity of dietary fat is consumed. 
Normally 7% or less of the ingested fat is detectable in the stool. In chronic 
pancreatitis, a two-stage test is more sensitive and specific. The test uses fecal 
collection with and without the use of pancreatic enzyme replacement to 
differentiate steatorrhea secondary to chronic pancreatitis from other causes. 
Steatorrhea due to chronic pancreatitis arises when 90% of pancreatic exocrine 
function has been lost. 
Plasma cholecystokinin (CCK) may be elevated in chronic pancreatitis 
patients compared with those with normal pancreatic function. 
Tests of pancreatic exocrine function may directly measure enzyme or 
bicarbonate secretions, or indirectly demonstrate malabsorption of a compound 
that requires pancreatic digestion for normal absorption. None of the methods 
targeted at exocrine function are absolutely accurate in terms of assessing 
exocrine secretion. In addition, none of these secretion assays appears to be 
able to differentiate chronic pancreatitis from carcinoma of the pancreas. 
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Radiological Testing 
Plain Abdominal Film 
A plain film of the abdomen is usually the first diagnostic test used to 
establish a diagnosis of chronic pancreatitis. Diffuse, speckled calcification of 
the gland may suffice as a positive finding 
 
   Figure 11. Abdominal x-ray showing diffuse calcification. 
Transabdominal Ultrasound 
Transabdominal ultrasound is a simple, noninvasive, and relatively 
inexpensive imaging technique. Findings of a dilated pancreatic duct (greater 
than 4 mm),calcification, and large cavities (greater than 1 cm) are associated 
with chronic pancreatitis. With a 70% sensitivity and 90% specificity, a 
satisfactory ultrasound examination negates the need for additional 
confirmatory testing. 
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Computed Tomography (CT) 
More sensitive than transabdominal ultrasound, CT (computed 
tomography) scanning can demonstrate duct dilation, cystic lesions, and 
calcification (Figure 12). This technique is useful in discriminating chronic 
pancreatitis from pancreatic carcinoma.  
 
Figure 12. CT scan demonstrating chronic pancreatitis. 
Magnetic Resonance Cholangiopancreatography (MRCP) 
Magnetic resonance cholangiopancreatography (MRCP) represents a 
major advance in the demonstration of pancreatic ductal anatomy. MRCP 
yields satisfactory pancreatograms in patients with chronic pancreatitis in 
whom a CT scan showed no abnormalities. No ductal or intravenous injection 
of contrast medium is necessary,and the patient is not exposed to irradiation. 
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MRCP is derived from an enhanced MRI and may be adjusted to optimally 
visualize the biliary and pancreatic ducts (Figure 13). Dynamic secretin 
magnetic resonance pancreatography (DSMRP) has further advanced 
pancreatic visualization. DSMRP may improve the clinician's ability to detect 
early chronic pancreatitis. Further studies are needed to fully assess this novel 
approach. 
 
Figure 13. MRCP demonstrating chronic pancreatitis. 
Endoscopic Diagnosis Gastrointestinal endoscopy allows the physician 
to visualize and biopsy the mucosa of the upper gastrointestinal tract. 
Endoscopy permits visualization of the esophagus, stomach and duodenum. 
The enteroscope allows visualization of at least 50% of the small intestine, 
including most of the jejunum and different degrees of the ileum. During these 
procedures, the patient may be given a pharyngeal topical anesthetic that helps 
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to prevent gagging. Pain medication and a sedative may also be administered 
before the procedure. The patient is placed in the left lateral position 
(Figure 14). 
 
 
Figure 14. Room set-up and patient positioning for ERCP. 
An endoscope is a thin, flexible, lighted tube that is passed through the 
mouth and pharynx and into the esophagus. The endoscope transmits an image 
of the esophagus, stomach and duodenum to a monitor, which is visible to the 
physician. The endoscopy room is equipped with an x-ray machine and monitor 
screen, which are used to help identify bile and pancreatic ducts. The 
endoscope introduces air into the stomach, expanding the folds of tissue and 
enhancing the examination of the stomach.  
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Position of the scope in the duodenum for ERCP. 
Endoscopic Retrograde Cholangiopancreatography (ERCP) 
ERCP is an endoscopic technique for visualization of the bile and 
pancreatic ducts. During this procedure, the physician inserts a side-viewing 
endoscope (Figure 16) in the duodenum facing the major papilla (Figure 15B). 
The side-viewing scope (duodenoscope) is specially designed to facilitate 
placement of endoscopic accessories into the bile and pancreatic ducts. The 
endoscopic accessories may be passed through the biopsy channel (Figure 16) 
into the ducts. A catheter is used to inject dye into both pancreatic and biliary 
ducts to obtain x-ray images using fluoroscopy (Figure 14). During the 
procedure, the physician is able to see two sets of images: the endoscopic 
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image of the duodenum and major papilla, and the fluoroscopic image of the 
bile and pancreatic ducts.  
The endoscope is designed to be held in the left hand, with the thumb 
operating up and down angulation. The index finger operates the suction and 
air/water operations. The right hand is responsible for advancing, withdrawing 
and torquing the insertion tube. The right hand also operates left and right 
angulation of the endoscope and passes accessories through the instrument. A 
variety of instruments can be utilized through the endoscope (Figure 15B). 
Electrosurgical devices, such as snares, biopsy forceps, heater probes; BICAP 
devicesfor polyp removal and cauterization, dilation balloons, stents, catheters, 
and esophageal prostheses can be used. Lithotripsy devices, injection devices, 
brushes,forceps, scissors, and magnetic extraction devices may also be inserted 
through the endoscope. Cameras may be attached for photo-documentation and 
dual examiner viewing. Video cameras may also be attached for full-color 
motion picture viewing during endoscopic procedures or for later review.ERCP 
is a sensitive and specific diagnostic tool in chronic pancreatitis. ERCP shows 
details of the pancreatic ductal anatomy, including strictures, ductal rupture and 
pseudocysts (Figure 17) .Remarkable advances have been made in endoscopy 
over the last 25 years. Video technology has made gastrointestinal endoscopy 
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easier for the endoscopist and safer for the patient, and it facilitates a greater 
transfer of clinical information.The future holds the promise for even better 
devices  and technology.  
 
Figure 17. A, B, ERCP of normal pancreatic and biliary ducts. 
The changes seen on ERCP (Figure 18A) are often inadequate to be of 
diagnostic value in the patient with chronic pancreatitis. Mild pancreatitis may 
present with minimal dilation of the main pancreatic duct and some clubbing of 
the side branches of the duct (Figure 18B).  
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Figure 18. A, B, ERCP demonstrating mild chronic pancreatitis. 
The patient with moderately-staged chronic pancreatitis shows moderate 
dilation of the main pancreatic duct (1.5 times the normal size) on endoscopic 
retrograde cholangiopancreatography (Figure 19A). This is accompanied by 
moderate clubbing of the side branches of the main pancreatic duct (Figure 
19B) 
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Figure 19. A, B, ERCP demonstrating moderate chronic pancreatitis. 
A characteristic "chain of lakes" appearance of the main pancreatic duct 
can be noted on ERCP in patients with severe chronic pancreatitis (Figure 
20A). The main pancreatic duct is enlarged (greater than 1.5 times) with 
increased tortuosity. There is severe clubbing and dilation of the side branches. 
Stone formation and occlusion of the pancreatic duct may occur in this stage of 
the disease (Figure 20B). On surgical examination of the organ, the gland is 
hard and grainy, and may beyellowish-gray. 
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Figure 20. A, B. ERCP demonstrating severe chronic pancreatitis. 
Endoscopic Ultrasonography (EUS) 
Endoscopic ultrasonography is the most sensitive imaging tool for the 
diagnosis of chronic pancreatitis, and has been proven to be more accurate than 
the CT scan.Endoscopic ultrasound is a highly technical, low-risk diagnostic 
procedure that utilizes high-frequency ultrasound during endoscopy to evaluate 
and diagnose digestive tract disorders. EUS allows imaging of the pancreas at 
close proximity with high resolution. Hence, it may detect changes consistent 
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with chronic pancreatitis in the patient in whom ERCP and other tests are 
normal. An EUS scope is advanced within the gastrointestinal tract against, or 
in close proximity to, the pancreas. From a position in the stomach or 
duodenum, the endoscope allows visualization of the pancreas and adjacent 
structures (Figure 21C).  
 
Figure 21. A, Radial and B, linear array EUS scopes; C, in position to scan 
pancreas; D, corresponding EUS image. 
There are two types of EUS scopes: radial scanning (Figure 21A) and 
linear array (Figure 21B).The radial type scans in a plane perpendicular to the 
axis of the scope (Figure 21A) to produce 360º images similar to a CT "slice" 
(Figure 21C and D).The transducer appears as a "bull's-eye within the image  
(Figure 22).  
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Figure 22. EUS image of a normal pancreas. 
The high resolution of the image allows clear differentiation between 
normal (Figure 23) and diseased ducts (Figure 24). The linear array type 
(Figure 23) scans in a plane parallel to the axis of the scope. It has the 
advantage of allowing visualization of the needle while performing a procedure 
(see Figure 30, EUS celiac plexus block). EUS allows the endoscopist to 
perform fine needle aspiration of lesions to differentiate malignancies from 
focal chronic pancreatitis.  
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Figure 23, 24. Comparison of EUS of normal pancreas and EUS of chronic 
pancreatitis. 
Therapy 
 
Overview 
Chronic pancreatitis patients require supportive measures. The initial 
stage in management of patients with chronic pancreatitis should include 
assessment of the etiology and severity of the disease, because both of these 
factors affect the mode of treatment. Treatment is generally directed toward 
control of pain, correction of problems related to pancreatic exocrine and 
endocrine insufficiency, and the correction of associated biliary tract and 
gastrointestinal tract pathology . 
Abdominal pain is a difficult symptom to treat in chronic pancreatitis. 
Because pain is a subjective sensation, there is no objective parameter for 
measurement or means to monitor its occurrence. 
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Medical Therapy 
Alcohol and Cigarette Smoking 
Avoidance of alcohol ingestion decreases the frequency and the severity 
of abdominal pain. Cigarette smoking has been correlated with intraductal 
calcifications in chronic pancreatitis patients. Also, both alcohol and cigarette 
smoking correlated significantly with number of pain relapses. Patients with 
chronic pancreatitis should be advised to avoid cigarettes and alcohol. 
Analgesics 
Non-narcotic analgesics (salicylates, acetaminophen, ibuprofen and 
nonsteroidal analgesics) should be used initially for pain control. These drugs 
should be used before meals to prevent postprandial exacerbation of pain. 
Dosage should be individualized, beginning with the lowest effective dose. 
With increased severity of pain,dosing frequency and strength should be 
increased. Episodes of severe abdominal pain may require limited use of 
narcotic analgesics such as acetaminophen with codeine. Opiate analgesics are 
required in severe cases of chronic pancreatitis. The pain of chronic pancreatitis 
is usually intermittent and postprandial, but when pain becomes persistent, 
affecting the patient's lifestyle, effective pain management becomes the most 
crucial part of treatment. 
37 
 
Enzyme Therapy 
The therapeutic goal of pancreatic enzyme therapy is to control diarrhea 
and help the patient to gain body weight. Many physicians advocate the use of 
pancreatic enzymes with acid suppression to inhibit pancreatic secretion and 
possibly decrease pancreatic intraductal pressure, and lessening pain. Enzyme 
therapy in chronic pancreatitis is critical for management of malabsorption 
problems. Diarrhea symptoms significantly improve with oral pancreatic 
enzyme therapy (with at least 24,000–32,000 units of lipase), but complete 
correction of steatorrhea is sometimes difficult to achieve, even with large 
amounts of enzyme supplementation. The clinical usefulness of pancreatic 
enzymes may be assessed by the patient's weight, ideally gaining two pounds 
each week and stabilizing at 10% below ideal body weight. 
Treatment of Malnutrition 
A result of maldigestion and malabsorption of fats, carbohydrates and 
proteins, protein energy malnutrition is a frequent abnormality in patients with 
chronic pancreatitis. Therapy for protein energy malnutrition requires 
correction of malabsorption, and administration of high-protein, high-calorie 
diets. In severely malnourished chronic pancreatitis patients, total parenteral 
nutrition may be the preferred treatment. The pancreas is nutrition-sensitive; 
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consequently, malnutrition may lead to atrophy or fibrosis. Medium-chain 
triglyceride preparations are a good source of lipid calories for this group of 
patients. However, nausea and unpleasant taste frequently limit its use. 
Surgical Therapy 
The progression of chronic pancreatitis is not always predictable, but 
typically the disease can be characterized by intractable abdominal pain, a state 
of exhaustion resulting from lack of food and water, chronic depression, and 
often chemical dependency. Although the malabsorption and diabetes mellitus 
associated with chronic pancreatitis can be treated medically, intractable pain 
ultimately becomes a major surgical indication in approximately one-third of 
patients. There is controversy over the role and timing of surgery in 
management of the patient with chronic pancreatitis. Early intervention is 
recommended to prevent irreversible functional impairment of the pancreas. 
Because the surgery is not uniformly successful and there is a significant 
recurrence of symptoms, others advocate expectant therapy. 
There is no single surgical procedure uniformly recommended for all 
patients with chronic pancreatitis. The surgical procedure is selected according 
to the severity of pain, ductal morphology, the extent of parenchymal disease, 
and the overall condition of the patient. The goal of surgery in chronic 
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pancreatitis patients is to relieve intractable pain while preserving endocrine 
and exocrine functions of the pancreas. The results of surgical procedures are 
inconsistent in their ability to control pain. 
The Puestow Procedure 
The longitudinal pancreaticojejunostomy, or Puestow's procedure, is the 
prototypic drainage procedure for patients with marked dilation of the main 
pancreatic duct (greater than 7–8 mm). An 8–10-cm segment of the pancreatic 
duct is unroofed and intraductal concretions removed (Figure 25A). The 
jejunum is divided (Figure 25B) and the opened pancreatic duct is anastomosed 
to the jejunum (Figure 25C). This allows adequate drainage to enter the 
jejunum. A jejunojejunostomy reconnects the jejunum to restore continuity of 
the gastrointestinal tract (Figure 25D). This procedure is successful in relieving 
pain in 70–80% of patients in the short term. Pancreatic function remains 
unchanged because there has not been resection of the gland. It is a safe and 
effective surgery with low morbidity and mortality.  
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Figure 25. The Puestow procedure. 
FREY’S PROCEDURE 
Local Resection of the Head of the Pancreas with 
Longitudinal Pancreatico-Jejeunostomy 
In 1987 the local resection of the head of the pancreas combined with 
longitudinal pancreatico-jejunostomy (LRLPJ)was described by Frey and 
Smith [69] (Fig. 4). The operation combined features of Child’s 95% distal 
pancreatectomy in the head of the pancreas (with whom Frey worked while at 
the University of Michigan) and the longitudinal pancreatico-jejunostomy of 
Puestow. In 1994, after an average follow-up of 3½ years, the results of 50 
cases were reported [70]. Pain was relieved in 80% of the patients and exocrine 
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and endocrine insufficiency followed the natural history of chronic pancreatitis 
and did not seem to be affected by the operation.The operation was designed to 
remove most of the head of the pancreas (the so-called pacemaker of the 
disease)while preserving the body and tail of the pancreas, the stomach, and 
duodenum to minimize morbidity. Although drainage of the main pancreatic 
duct in the body and tail of the gland is usually performed because of the 
presence of post-stenotic dilatation and ductal stones, it may not be an essential 
part of the procedure if the main duct in the body and tail is open and 
uninflammed throughout its length. This“coring” of the pancreatic head with 
preservation of the posterior capsule is the essential feature of the LR-LPJ 
operation. It can be performed safely using the ultrasonic dissector and 
aspirator [71] (Fig. 5), or with a combination of suture plication and cautery. 
As with the DPPHR, it is important to recognize and preserve the 
intrapancreatic common bile duct.The DPPHR described by Beger has 
similarities to the LR-LPJ. Both are directed primarily at the disease in the head 
of the pancreas and both preserve gastrointestinal continuity. Not surprisingly, 
the results of both operations in terms of pain relief and quality of life appear to 
be similar. These 2 operations also have significant differences.The posterior 
capsule of the pancreas is preserved in the LR-LPJ, which allows the excavated 
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head(and dorsal duct) to be drained into a single, side-to-side pancreatico-
jejunostomy. The DPPHR does not preserve the posterior capsule, which 
mandates 2 anastomoses.The Beger operation requires that the pancreas be 
divided at its neck overlying the superior mesenteric and portal vein. In the 
event of portal hypertension and associated inflammatory changes, this may be 
technically difficult,but is avoided in the LR-LPJ 
 
 
Fig. 4. Local resection of the pancreatic head with longitudinal 
pancreatico-jejunostomy (LR-LPJ) or Frey procedure. The extended 
longitudinal Roux-en-Y pancreatico-jejunostomy with excavation of the 
pancreatic head provides complete decompression of the distal ductal system as 
well as removal of the nidus of chronic inflammation.  
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Fig. 5. Operative photograph of a completed excavation of the 
pancreatic head using the ultrasonic aspirator and dissector. Note the complete 
removal of the proximal ductal systems with preservation of the posterior 
pancreatic capsule. The longitudinal pancreatotemy reveals chronic 
inflammation of the ductal mucosa in the body and tail, consistent with 
recurrent inflammation due to chronic pancreatitis.  
 
 
Izbicki’s ‘‘V’’ shaped ventral pancreatic excision 
 
In this procedure a long ‘‘V’’ shaped excision of ventral aspect of the 
pancreas is done with a lateral pancreaticojejunostomy by a mucosa to capsule 
anastamosis. This procedure drains the main as well as the second and third 
order ducts.This is an ideal procedure for small duct disease with a maximum 
diameter of the Wirsung’s duct less than 3mm. In small duct chronic 
pancreatitis, longitudinal V-shaped excision of the ventral pancreas is a safe 
and effective alternative to resection procedures. The new technique provides 
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pain relief and improvement of quality of life, thus offering the benefit of a 
resection procedure without its burden.  
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MATERIALS AND METHODS 
TITLE 
 A COMPARITIVE STUDY OF  DRAINAGE PROCEDURES IN 
CHRONIC PANCREATITIS. 
Source of Data: 
 All cases of CHRONIC PANCREATITIS who attend govt. mohan 
kumaramangalam medical college hospital, will be evaluated clinically and by 
investigations and will be included in the study from may 2013 to march 2015. 
Sample size: 
Sample size of minimum of 32 patients fulfilling the inclusion criteria 
were part of this study. 
Method of Collection of Data: 
• Detailed history taking 
• Complete clinical examination 
• Investigations 
• Performing surgery for the cases, noting the findings and follow up 
of the 
• relief of symptoms and improvement of quality of life . 
• The details of the above have been given in the clinical proforma 
sheet and in the master chart. 
STUDY DESIGN  
Prospective cross sectional study 
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STUDY PERIOD  
2 years (May 2013 to march 2015) 
PLACE OF THE STUDY 
Govt.  Mohan Kumaramangalam Medical College Hospital, Salem. 
ETHICAL CLEARANCE   
Institutional Ethical clearance obtained 
Inclusion criteria:  
• Clinical & Radiological features of Chronic pancreatitis     with     
persistent    pain. 
•   Pancreatic ductal  dilatation 
•    severe malabsorption  
•    multiple relapse 
•    Pseudocyst  pancreas 
Exclusion criteria:  
 Patients unfit for prolonged anaesthesia  
  Pseudoaneurysm  
  Infected  Pseudocyst  
 Pancreatic   malingnancy  
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 Periampullary carcinoma with pancreatitis 
 Acute exacerbation of chronic pancreatitis           
 Patients  not willing for follow up 
STUDY METHODOLOGY 
 Patients who met inclusion and exclusion criteria for the study 
selected and all patients informed about the nature of the disease and possible 
complications (infection , wound dehiscence, persistent symptoms, post 
operative pain ) expected after surgery. Written consent for the study and 
surgery obtained. 
In proforma, thorough history, signs and symptom, clinical findings noted. 
• Blood glucose and urea, 
• Serum creatinine and electrolytes, 
• Complete Blood count 
• Urine routine examination 
• X ray chest PA view 
• ECG in all leads 
• cardiology fitness 
Specific investigations 
- x ray Abdomen AP erect 
- Transabdominal Ultrasonography  
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- Contrast Enhanced Computed Tomography 
- Magnetic Resonant Cholangiopancreaticography  
- ERCP 
- EUS 
PRE OPERATIVE PREPARATIONS 
* NPO for about 24 hrs before surgery,  
* consent for planned procedure 
* Abdomen  prepared on the previous day of  surgery 
 * Inj. Cefotaxime 1 gm IV before surgery 
* Inj. Ranitidine 50mg IV before surgery 
* Inj. TT 0.5cc IM 
* Inj. Xylocaine test dose 
PROCEDURES DONE 
1.  FREY’S PROCEDURE, 
2.  PUESTOW GILLESBY PROCEDURE & 
 3. IZBICKE’S PROCEDURE 
In our study cases of which 14 cases selected for  FREY’S 
PROCEDURE, 10cases for PUESTOW GILLESBY PROCEDURE, and 8 
cases IZBICKE’S PROCEDURE done. 
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- All cases done under general anesthesia. 
- All cases are done in supine position. 
- All cases are done in ROOF TOP incision. 
- All cases pancreaticojejunostomy and Roux en-y and jejunojejunostomy 
done. 
- Head coring done in FREY’S PROCEDURE. 
- B/L Flanks drain kept. 
POST OPERATIVE EVENTS 
Patients were shifted to the ward and adequate analgesics and antibiotics 
were given. Oral fluids were started after 5 of surgery. Dressing was changed 
on second post operative day. Normal diet was started from 7 th post operative 
day or as tolerated by the patients.Drains removed on 8 th pod after confirming 
that there is no anastomotic leak. If patients improved clinically, they were 
discharged and advised to attend surgical OPD for regular follow up.  
ASSESSMENT TOOLS 
Per operative complications 
* Intra operative Bleeding due to adhesions 
* Difficulty in identifying the main pancreatic duct 
* Duration of surgery  
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Post operative complications 
 post operative Bleeding 
 post operative pain 
 wound infection  
 Collection 
 wound dehiscence 
 Control of blood sugar 
 Anastamotic leak   
Complications on follow up 
• Recurrence of symptoms 
• uncontrolled Diabetics    
• malnourishment 
• Poor quality of life 
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RESULTS 
The patients presenting to the doctor for complaints relating to chronic 
pancreatitis only represent the tip of the ice berg. Many go unreported and 
under diagnosed or even misdiagnosed. A total of 32 patients were admitted 
with complaints relating to  chronic pancreatitis and its complications. The 
above patients were included in the study, findings noted, appropriate treatment 
instituted and followed up for a period of 6months. 
The study titled, “ A COMPARITIVE STUDY OF  DRAINAGE 
PROCEDURES IN CHRONIC PANCREATITIS” was conducted at 
GOVERNMENT MOHANKUMARAMANGALAM MEDICAL COLLEGE, 
SALEM from which the following observations are done 
1. Age and Gender distribution of the Study Population. 
In this study more than two third of the patients (68.2%) were less than 
40 years old. The Mean Age of the studied population was 34.8 ± 4.54 with 
minimum age being 32 and maximum age being 53 years            
In this study majority (93.4%) of the study population was Males and 
Females consisted of only a few (6.6%). The male: female ratio was noted to be 
approximately 15:1 in this study.      
 
 
 
 
 
52 
 
               
Table No. 01: Age and Gender distribution of the Study Population. 
 
Variable Frequency Percent 
Gender 
Male 30 93.75 
Female 2 6.25 
Total 32 100.0 
 
 
Graph  No. 01: Gender distribution of the Study Population. 
 
MALE
FEMALE
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Age Groups 
< 25 Years 1 3.12 
25 – 30 4 12.50 
30 – 35 9 28.13 
> 35 years 18 56.25 
Total 32 100.0 
 
 
Graph  No. 02: Age Distribution of the Study Population. 
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Table No. 03:CECT  findings in the patients.  
Findings Frequency Percent 
Duct and 
parenchymal 
caicification only 
8 25 
Main pancreatic 
duct dilatation only 
2      6.25 
Both findings 22      68.75 
Total 32 100.0 
 
Graph No. 03:CECT findings  in the patients. 
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04.Disribution of the patients based on the type of treatment procedure 
Performed. 
 The patients were managed by one of the three procedures 
namely .       
1.   FREY’S PROCEDURE, 
2.  PUESTOW GILLESBY PROCEDURE & 
3. IZBICKE’S PROCEDURE. 
Out of 32 patients 14 patients underwent .   FREY’S PROCEDURE, 10 
patients underwent.  PUESTOW GILLESBY PROCEDURE and 8 patients 
underwent IZBICKE’S PROCEDURE. 
Table no.4 Distribution of the patients based on the type of 
treatment procedure Performed. 
 
 
Procedure Frequency Percent 
FREY’S PROCEDURE 14 43.75 
PUESTOW GILLESBY 
PROCEDURE 
10 31.25 
IZBICKE’S PROCEDURE. 8 25 
TOTAL 32 100.0 
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Graph No. 04: Disribution of the patients based on the type of treatment 
procedure Performed. 
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05. Distribution of the Patients on the basis of duration of Surgery. 
It was observed that the time taken for operating on the patients was 
more than three hours in all the patients treated surgically for chronic 
pancreatitis. In contrast, frey’s procedure required greater time of more than 
half hour for performance of coring of the head. Highly significant statistical 
association was observed between the duration of surgery and the treatment 
groups. The mean duration of surgery was highest among Frey’s procedure 
treatment group followed by Izbicke’s procedure and Puestow  procedure.                                  
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Table No. 05: Distribution of the treatment groups based on the duration 
of Surgical Procedure Performed 
Variable 
Treatment Procedure 
Total p-value Frey’s Izbicke’s Puestow 
<3 Hour 
4 8 6 18 
0.00 
22.2% 44.4% 33.3% 100.0% 
28.6% 80% 75.0% 56.25% 
>3 Hour 
10         2 2 14 
71.6% 14.2% 14.2% 100.0% 
71.4% 20.0% 25% 43.75% 
Total 
14 10 8 32 
43.75% 31.25% 25.0% 100.0% 
100.0% 100.0% 100.0% 100.0% 
Mean 42.5 57.25 93 60.68 
S.D 4.27 6.58 4.21 19.6 
 
Graph No.05: Distribution of the Treatment Groups based on the 
Duration of Surgical Procedure Performed 
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06. Distribution of the Patients on the basis of duration of Hospital Stay. 
 It can be seen that nearly all of the patients treated by surgically had 
a hospital stay of more than three weeks duration.one week for preop 
evaluation and planning and two weeks for post op care.If the patient develops 
any post op complication like wound infection the hospital stay will prolong 
one more week.All the three groups treated by three different surgical 
procedures had the same duration of hospital day.The association between the 
duration of hospital stay and type of treatment procedure performed was not 
statistically not significant. 
Table No. 06: Distribution of the Patients on the basis of duration of 
Hospital Stay. 
 
Duration of 
Hospital stay 
FREY’S 
(14) 
PUESTOW 
(10) 
IZBICKE’S 
(8) 
No Of 
Cases 
% 
No Of 
Cases 
% 
No Of 
Cases 
% 
< 3 Week 5 35.7 3 30 3 37.5 
>3Weeks 9 64.3 7 70 5 62.5 
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Graph No.06 Distribution of the Treatment Groups and their Durationof 
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7. Distribution of the Study Groups on the Basis of the type of Treatment 
Procedure and Ease of Performance of Procedure. 
The surgeon perceived that it was easy to perform in 85.7% and 90% of 
the patients treated by Puestow procedure.   Whereas it was  little difficult to 
perform  Frey’s procedure and Izbicke’s procedure all the patients treated with 
such technique. This difference in the difficulty perception of the surgeon and 
the surgery technique was found to be statistically significant. 
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Table No. 07: Distribution of the Study Groups on the Basis of the type of 
Treatment Procedure and Ease of Performance of Procedure. 
Ease of 
Procedure 
Treatment Procedure 
Total 
p-value 
Frey’s Puestow Izbicke’s  
Easy 
2 6 2 10 
0.00 
20.0% 60.0% 20.0% 100.0% 
14.3% 60% 25% 31.25% 
Mild 
Difficult 
6 4 4 14 
42.8% 28.6% 28.6% 100.0% 
42.9% 40.0% 50.0% 9.1% 
  Difficult 
6 0 2 8 
75.0% 0%            25.0% 100.0% 
42.9%  0%      25.0% 22.7% 
Total 
14 10 8 32 
43.75% 31.25% 25% 100.0% 
100.0% 100.0% 100.0% 100.0% 
 
Figure No. 07: Distribution of the Study Groups on the Basis of the 
type of Treatment Procedure and Ease of Performance of Procedure. 
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8.Proportion of patients among the Treatment groups experiencing 
Complications in the Per-operative Period, Post-operative Period and 
Follow up Period. 
 Per operative complications were reported in larger number of 
patients undergoing Izbicke’s procedure (21.4%) followed by Frey’s procedure  
(20%) and Puestow’s procedure(15%). Post operative complications were 
observed equally in by Frey’s procedure and Puestow’s  procedures and more 
in Izbicke’s procedure. Recurrence was observed in Puestow’s procedure but 
not in Frey’s procedure and  Izbicke’s procedure. 
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Table No. 08: Proportion of patients among the Treatment groups 
experiencing Complications in the Per-operative Period, Post-operative 
Period and Follow up Period. 
Variable 
Treatment Procedure 
Total p-value 
FREY’S PUESTOW’S IZBICKES 
Per-operative Complications 
Absent 
8 6 6 20 
0.879 
40.0% 30.0% 30.0% 100.0% 
57.2% 42.9% 75.0% 62.5% 
Present 
6 4 2 12 
50.0% 33.3% 16.7% 100.0% 
42.9% 40.0% 25.0% 37.5% 
Total 
14 10 8 32 
43.75% 31.25% 25% 100.0% 
100.0% 100.0% 100.0% 100.0% 
Post-operative Complications 
Absent 
10 4        3 17 
0.751 
59.8% 23.5% 17.7% 100.0% 
71.4% 40% 37.5% 
    
53.1% 
Present 
4 6 5 15 
26.7% 40% 33.3% 100.0% 
28.6% 60.0% 62.5% 46.9% 
Total 
14 20 10 44 
43.75% 31.25% 25% 100.0% 
100.0% 100.0% 100.0% 100.0% 
Recurrence 
No 
12 4 5 21 
0.703 
57.1% 19.1% 23.8% 100.0% 
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85.7% 40% 62.5% 
      
65.6% 
Yes 
2 6 3 11 
18.1 54.6% 27.3% 100.0% 
14.3% 60.0% 37.5% 34.4% 
Total 
14 20 10 44 
43.75% 31.25% 25% 100.0% 
100.0% 100.0% 100.0% 100.0% 
                                  
Graph No. 08: 
Proportion of patients among the Treatment groups experiencing 
Complications in the Per-operative Period, Post-operative Period and 
FollowupPeriod
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09.Gender Distribution between the Study Population and the Treatment 
Groups. 
 Nearly half of the males (45%) were treated with Frey’s procedure 
where as in females, equal number of patients were treated with Frey’s 
procedure  and Puestow procedure. Equal number of patients aged less than 35 
years was treated with the three treatment procedures, whilst patients aged 
more than 35 years were treated with Frey’s procedure only. More number of 
patients (45.5%) was treated with Frey’s procedure. The association between 
the gender and age distribution with the type of treatment procedure followed 
was not statistically significant. 
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Table No.09: Gender Distribution between the Study Population and the 
Treatment Groups. 
 
Variable 
Treatment Procedure 
Total p-value 
FREY’S PUESTOW’S IZBICKES 
Gender 
Male 
Count 13 9 8 30 
0.239 
% within 
SEX 43.3% 30.0% 26.7% 100.0% 
% within 
Treatment 
Procedure 
92.9% 90.0% 100.0% 93.75% 
Female 
Count 1 1 0 2 
% within 
SEX 50% 50.0%  0% 100.0% 
% within 
Treatment 
Procedure 
7.1% 10.0%  0% 6.25% 
Total 
Count 14 10 8 44 
% within 
SEX 
43.75% 31.25% 25% 
100.0% 
% within 
Treatment 
Procedure 
100.0% 100.0% 100.0% 100.0%  
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Figure No. 09; Gender Distribution between the Study Population and the 
Treatment Groups. 
 
0
10
20
30
40
50
60
70
80
90
100
MALE FEMALE
FREY'S
PUESTOW
IZBICKES
 
 
  
67 
 
 
Table No. 10:Distribution of the patients on the basis of their Occupation 
and Treatment groups. 
Variable 
Treatment Procedure Total p-value 
FREY’S PUESTOW’S 
IZBICKE
S   
Manual 
labourer 
Count 9 7 5 21 
0.927 
% within 
OCCUPATION 42.9% 33.3% 23.8% 
100.0
% 
% within 
Treatment 
Procedure 
64.3% 70.0% 62.5% 
65.6
% 
Business 
Count 2 0 3 5 
% within 
OCCUPATION 
25% 0% 75% 
100.0
% 
% within 
Treatment 
Procedure 
14.3% 0% 37.5% 
12.5
% 
Clerk/ 
Executive 
Count 2 2 0 4 
% within 
OCCUPATION 50.0% 50.0%   0% 
100.0
% 
% within 
Treatment 
Procedure 
14.3%         20.0%          0% 9.4%  
Others 
(including 
house 
wifes) 
Count 1 1 0      2 
 
% within 
OCCUPATION 
50.0% 50.0% 0% 
100.0
% 
% within 
Treatment 
Procedure 
7.1% 10.0% 0% 
31.8
% 
Total 
Count 14 10 8 32 
% within 
OCCUPATION 
43.75% 31.25% 25% 100.0
% 
% within 
Treatment 
Procedure 
100.0% 100.0% 100.0% 
100.0
% 
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 Nearly half of the Manual labourers were treated with Frey’s procedure 
(42.9%) whilst others were treated with puestow (33.3%) and 
Izbicke’sprocedures (28.4%).  Businessman and clerks/executives were equally 
treated with all the three procedures.   
 Figure No. 10: Distribution of the patients on the basis of their 
Occupation and Treatment groups. 
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11.Distribution of the Treatment Groups and Time taken for complete 
Wound Healing. 
Table No.11: Distribution of the Treatment Groups and Time taken for 
complete Wound Healing. 
Variable 
Treatment Procedure 
Total 
p-
value FREY’S PUESTOW’S IZBICKES 
< 
2Weeks 
12 8 6 26 
0.00 
46.2% 30.8% 23.0% 100.0% 
85.7% 80.0% 75.0% 81.3% 
>2Weeks 
      1 1 2 4 
25.0% 25.0% 50.0% 100.0% 
7.2% 10.0%     25.0% 9.1% 
> 
1Months 
1 1 0 2 
50.0% 50.0% 0.0% 100.0% 
7.1% 10.0% 0.0% 4.6% 
Total 
14 10 8 32 
43.75% 31.25% 25% 100.0% 
100.0% 100.0% 100.0% 100.0% 
Mean 67.57 12.45 20.90 31.91 
S.D 10.18 4.25 4.31 25.72 
 
Most of  the  Patients treated by all the three procedures took lesser 
duration for complete wound healing (Less than two week. It was observed that 
there is no difference between the all the three procedures. 
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Figure No. :11.  Distribution of the Treatment Groups and Time 
taken for complete Wound Healing.    
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POSTOPERATIVE PAIN ASSESMENT  BY VISUAL ANALOGUE SCORE 
 
A Visual Analogue Scale (VAS) is a measurement  instrument  that tries to 
measure a characteristic or attitude that is believed to range across a continuum 
of values and cannot easily be directly measured. For example, the amount of 
pain that a patient feels ranges across a continuum from none to an extreme 
amount of pain. From the patient's perspective this spectrum appears 
continuous ± their pain does not take discrete jumps, as a categorization of 
none, mild, moderate and severe would suggest. It was to capture this idea of 
an underlying continuum that the VAS was devised.Operationally a VAS is 
usually a horizontal line, 100 mm in length, anchored by word descriptors at 
each end. The patient marks on the line the point that they feel represents their 
perception of their current state. 
The VAS score is determined by measuring in millimetres from the left 
hand end of the line to the point that the patient marks. 
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PAIN SCORE 
(N = 32 PATIENTS) 
CRITERION 
 
PREOPERA
TIVE 
SCORE 
(MEDIAN 
RANGE) 
 
POSTOPERATIVE FOLLOW UPSCORE 
(MEDIAN RANGE) 
 
P 
VALUE FREY’S PROCEDU
RE 
PUESTO
W’S 
PROCED
URE 
PREOPERATI
VE SCORE 
 
Pain visual 
analog 
Scale 
81 6 16 12 P<0.01 
Frequency of 
pain 
Attacks 
75 0 4 2 P<0.01 
Pain 
medication 17 0 4 2 
P<0.01 
Inability to 
work 75 0 10 6 
P<0.01 
Pain score* 62 2 10 6 P<0.01 
 
* The pain score was defined as the sum of the rank values of the 
four criteria divided by four;  
 
Occupational rehabilitation was achieved in 21 of 32 patients 
(65%). 
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QUALITY OF LIFE ASSESSMENT: FUNCTION SCALES (N = 32 PATIENTS) 
 
  POSTOPERATIVE SCORE  
FUNCTIONAL 
SCALES 
PREOPERATIVE 
SCORE 
 
FREY’S 
PROCEDURE 
PUESTOW’S 
PROCEDURE 
IZBICKE’S 
PROCEDURE 
P 
VALUE 
Physical status 60 100 80 82.6 P<0.01 
 
Working 
ability 
 
50 100 84.8 86 P<0.01 
Cognitive 
functioning 
 
50 66.7 62.2 65.8 P<0.01 
Emotional 
functioning 
 
25 75.0 65.8 72.6 NS 
Social 
functioning 
 
16.7 66.7 60.6 64.8 P<0.01 
Global 
quality of 
life 
28.6 85.7 75.8 80.6 NS 
  
 
NS = not significant. 
* Statistical analysis: Wilcoxon rank test. 
Occupational rehabilitation was achieved in 21 
out of 32 patients (65%). 
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PEROPERATIVE PICTURES 
 
ROOF TOP INCISION 
 
 
IDENTIFYING THE PANCREATIC DUCT 
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OPENING THE JEJUNUM 
 
 
LONGITUDINAL PANCREATICOJEJUNOSTOMY 
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SIDE TO SIDE PANCREATICO JEJUNOSTOMY 
 
 
              END TO SIDE JEJUNO-JEJUNOSTOMY 
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DISCUSSION 
Chronic pancreatitis is a progressive inflammatory disorder 
characterized by irreversible destruction of pancreatic parenchyma and may be 
associated with disabling chronic pain and permanent loss of endocrine and 
exocrine function. Main indication for surgery is intractable abdominal pain 
and choosing the best technique to be used for a patient remains a challenge. 
Sex incidence 
 The disease is more common in males than females for reasons like 
Alcoholism, smoking and occupation. The western literature also confirms that 
this disease is predominant in males. The Indian male for obvious reasons like 
Alcoholism, smoking and occupation were noted to be more prone for the 
disease than the female counterpart. In this study majority (93.75%) of the 
study population was Males and Females consisted of only a few (6.25%). The 
male: female ratio was noted to be approximately 15:1 in this study.  
Age incidence 
The disease occurs rarely in subjects beyond 50years for reasons that 
have already been explained. It is more commonly seen in the age groups of 30 
to 40 years because the time taken for the manifestation of the disease is high. 
Females tend to develop this disease at an earlier age than the male 
counterparts because the etiology is different in females compare to males. 
 In this study more than two third of the patients (81.38%) were between 
the age group of 30 to 40 years. The Mean Age of the studied population was  
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6.8 ± 4.54 with minimum age being 24 and maximum age being 51 years, 
which is comparable with, other standard studies namely.  
Occupation incidence 
 Occupation has an important role in the development of chronic 
pancreatitis. It’s seen in people who are manual labourers who are more for 
chronic alcoholism and smoking to overcome the stress and strain from their 
prolonged work.. In this study nearly 2/3 rd (75.0%) of the patients were 
manual iabourers by occupation. businessman consisted of about 12.5% of the 
population.  
Body Mass Index 
Most of the patients presented with chronic alcoholism are malnourished 
due to loss of appetite and exocrine and endocrine deficiency. Over weight and 
obesity are considered to be less contributing factor.  
Investigation 
Diagnosis of chronic pancreatitis is mostly clinical and by radiological 
imaging. There  specific investigations that are needed for the confirmation of 
endocrine and exocrine deficiency are available.x ray abdomen, ultrasound 
abdomen,CECT Abdomen, MRCP are routinely done in these patients to know 
the duct and parenchymal calcification,duct diameter, and to rule out CBD and 
Gallbladder pathology. 
Treatment 
Among the 32 patients,14 patients underwent FREY’S PROCEDURE, 
10  patients underwent PUESTOW PROCEDURE and 8 patients underwent 
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IZBICKE;S PROCEDURE.All the patients treated with B/L flank drains and 
kept on nil oral for 5 days.Drains were removed on 7th  POD after confirming 
that there is no anastomotic leak.All are given IVantibiotics for 7 days. 
 Nearly half of the males (43.3%) were treated with Frey’s procedure 
and 30% of males treated with Puestow procedure. where as in females, equal 
number of patients were treated with Frey’s procedure and Puestow procedure.  
Time taken for surgery 
Average time taken for Puestow and Izbicke’s procedure were 3 hours. 
Extra 30 to 45 minutes were taken for Frey’s procedure in which the head 
coring has to be done.This time includes from time of induction to recovery of 
the patient from Anaesthesia. 
Complications 
Per operative complications mainly excessive bleeding noted in more 
number of patients with previous abdominal surgeries with adhesions.In other 
cases the dissection was easy and there was no significant per operative 
complications. 
In few cases post op wound infection occurred which was treated with 
appropriate antibiotics and dressings and allowed to heal by secondary 
intention. 
Post operative diabetic management was difficult in most of the cases 
for which Diabetologist opinion obtained and Insulin was given.Nutrition 
support was given to most of the patients. 
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Duration of hospital stay 
 It can be seen that more than half of the patient (65.6%) treated by all 
the three procedures  had a hospital stay of more than three weeks duration, 
which includes preoperative evaluation.The hospital stay is prolonged in 
patients who had wound infection and uncontrolled Diabetes. The association 
between the duration of hospital stay and type of treatment procedure 
performed was statistically not significant.  
Recurrence 
 Recurrence of pain was more among patients underwent Puestow 
procedure( 60%)  followed by ( 37.5%) in Izbicke’s procedure and least rate of 
reccurence was noted in Frey’s procedure. 
 
The results of most studies on the control of pain after surgical treatment 
of CP have limitations and interpretation of comparison due to lack of 
standardization of data collection on thissymptom. Also subjective symptom, 
evaluation of abdominal pain as a criterion for surgical success in postoperative 
should be taken with caution, since it is influenced by a series of psychological 
and social factors. The coexistence of mental disorders in alcoholics and 
patients dependent on opioids may interfere with the results of treatment. For 
this reason, the service of the authors routinely requires discontinuation of 
alcohol intake and consumption of cigarettes and narcotics, providing 
psychosocial support for these patients so that they can deliver better results not 
only in pain control, but also in global recovery. Thus, it is observed that the 
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operation is only part of a complex and multidisciplinary treatment that begins 
to prepare the patient for the procedure and should continue throughout the 
postoperative follow-up.The largest national study of the technique of Frey 
showed results of pain management in long-term similar to other published 
reports of remission of 91.4% in painful mean follow-up of 77 months. The 
results are consistent with those observed with most published series . 
Time taken to heal 
Average period for wound healing was two weeks in all the three  
procedures.The wound healing was prolonged in patients who had post 
operative wound infection and subsequent wound gapping which healed by 
secondary intention. The association between the time taken for wound healing 
and type of treatment procedure performed was statistically not significant.  
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CONCLUSION 
In our study of 32 patients who presented with clinical and radiological 
features of chronic pancreatitis  the following observations were made: 
1. Recurrent attacks of abdomen pain and progressive insufficiency of               
endocrine and exocrine organ function. 
2. It is more common in patients with alcohol abuse. 
3. It’s a diagnosis based on history, clinical findings, radiological 
investigations like ultrasound abdomen,CECT abdomen and MRCP 
in selective cases. 
4. Treatment of chronic pancreatitis mainly focused on pain 
management,treatment of exocrine and endocrine 
insufficiency,prevention of weight loss and prevention of disease 
progression. 
5. Duct drainage,Radical resective surgery and local resections are the 
most common surgical techniques in the surgical theraphy. 
6. In this study three main surgical procedures namely FREY’S, 
PUESTOW and IZBICKE’S procedure were compared. 
7. The difference between the duration of surgery, hospital stay, wound 
healing, per op and post op   complications are satistically not 
significant.But the reccurence of symptoms is very low in FREY’S 
procedure (14.3%) compare to 37.5% in IZBICKE’S procedure and 
60% in PUESTOW’S procedure. 
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8. Frey´s, proved to be highly effective in controlling abdominal pain 
secondary to this disease in longterm,combined with small 
interference on exocrine and endocrine function. 
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SUMMARY 
• Chronic pancreatitis is a relatively rare disorder occurring in about 20 
per 100,000 population. 
• Chronic pancreatitis is characterized by inflammatory changes of the 
pancreas with  fibrosis, calcification, pancreatic ductal inflammation, 
and pancreatic stone formation. 
• It is more common in males compared to the females. 
• Chronic alcoholism is the most common aetiological factor for 
developing chronic pancreatitis. 
• Local resection of the pancreatic head, with or without duct drainage 
offer outcomes as effective as pancreaticoduodenectomy. 
• Ductal hypertension with activation of stretch fibers and peripancreatic 
sensory nerve damage are the main causes for pain in chronic 
pancreatitis 
• The recurrence of pain was often attributed to persistent or recurrent 
disease in the head of the pancreas. 
• Pancreatico-duodenectomy(Whipple procedure), duodenal-preserving 
pancreatic head resection (DPPHR or Beger procedure), and local 
resection of the pancreatic head with extended longitudinal pancreatico 
jejunostomy (LR-LPJ or Frey procedure) are the three operative 
approaches have proven to be efficacious in chronic pancreatitis. 
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• The longitudinal pancreaticojejunostomy, or Puestow's procedure, is the 
prototypic drainage procedure for patients with marked dilation of the 
main pancreatic duct. 
• Local resection of the pancreatic head with longitudinal pancreatico-
jejunostomy (LR-LPJ)  is  known as Frey procedure. 
• Longitudinal V-shaped excision of the ventral pancreas for small duct 
chronic pancreatitis with pancreaticojejunostomy is known as 
IZBICKE’S procedure. 
• Among all, it is the Frey  procedures which have a low recurrence rate.   
Surgical treatment of CP with anterior resection of the pancreatic 
head associated with pancreatojejunostomy, technique known as 
Frey´s, proved to be highly effective in controllingabdominal pain     
secondary to this disease in longterm, combined with small 
interference on exocrine and endocrine function. The technique of 
Frey should be considered as primary treatment for patients with 
CP accompanied by abdominal pain and increase in volume of the 
pancreatic head, because it is safe and easier to perform with less 
morbidity and more tality than other techniques. 
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ANNEXURE 
PATIENT PROFOMA 
NAME  : 
AGE   : 
SEX   : 
ADDRESS  : 
IP NUMBER  : 
DOA   : 
DOS   : 
DOD   : 
CHIEF COMPLAINTS: 
ABDOMEN PAIN  : 
 DIABETES MELLITUS : 
WEIGHT LOSS  : 
STEATORRHOEA  : 
PAST HISTORY; 
TREATMENT DETAILS; 
ANY   OTHER ASSOCIATED ILLNESS; 
 
 
PERSONAL HISTORY: 
OCCUPATION ;        
CLINICAL EXAMINATION: 
CONSCIOUS LEVEL   : 
ANAEMIA-PRESENT/ABSENT  : 
ICTERUS/CYANOSIS/CLUBBING/PEDAL: 
EDEMA     :  
VITAL SIGNS:  PULSE : 
BLOOD PRESSURE    : 
TEMPERATUR               : 
RESPIRATORY RATE   : 
CARDIOVASCULAR SYSTEM  : 
RESPIRATORY SYSTEM  : 
ABDOMEN EXAMINATION  : 
PER RECTAL ABDOMEN  :    
INVESTIGATIONS   : 
 
 
 
 
COMPLETE BLOOD COUNT- 
BLOOD-           urea -           sugar –  
SERUM-          creatinine -            electrolytes - 
Cardiology fitness: 
X ray chest- 
SPECIFIC INVESTIGATIONS; 
ULTRASOUND ABDOMEN: 
CECT ABDOMEN: 
MRCP: 
DIAGNOSIS: 
PROCEDURE DONE: 
Post Operative Period 
Management 
Complications 
FOLLOW UP OF PATIENTS: 
6 weeks 
12 weeks 
3mont 
RESULT: 
 
 
ேநாயாளி ஒப்�த ் ப� 
�ைலப்: “அ�ைபசிகிசைச ைையி   COMPARITIVE STUDY OF  
DRAINAGE PROCEDURES IN CHRONIC PANCREATITIS. 
��்�� ஒப்ி்�ி�ம, அர� ேமாகி மாரமமகல� ம் மப கதவாி 
மற�� ம் மபமைவ, ேசல�” 
ெ்ாம அ�ைபசிகிசைச மைை 
 
ேநாயாளியி  ெ்யய:     பயம:            ிண/ெ்ண 
ம்.எண: 
எவக  இ� அ�ைபசிகிசைசயி  ேநாகக�, மற�� அ�ி ெசயத ைை 
அைவ ம� நி  ்ாிஇ�ம எவ ��ி அளிககிேைி. எவக  அ�ைபசிகிசைச 
்றைிய சஇே�கமகைள ேக க பா�ப் அளிககப் ிம எவம�, அவபா� 
ேக கப் ி ெ்ாெம, சஇே�கமக் யாம� எவக  ெ�ளிபாக எ் மைரககப் ிம 
எவம� ெ�ாிபிககிேைி. 
அ�ைபசிகிசைசயி  ெ்ாெம� அ�ி ்ி வ்� ்ற்ி பா�ப்்ள 
்ி பிைைமக் யாம� எவக  ெ�ளிபாக எ் மைரககப் ிம. ேம�� இ� 
ி�பித நாி எவம ெசாஇ� பி்ப் �ி  ெ்யாித ்மகளிககிேைி எி்�ைவ��, 
ே�ைபப் ிாத எஇ� பிளகக � அளிககாமத ி�பித ்இம எிவாத 
பிலகிகெகா்ள  �� எி்�ைவ�� நாி நி  அைிேபி. 
ேம��, எவம ிதநல ்�ிேப்கைள இ� ி�மகேகா, ்ிறகால �ித 
 இ� ி�ம ெ�ாிய்ாவ மறை ி�மகஆகேகா ்யி்் �ிகெகா்ள, 
ி�பாள்கேகா, க ்ப்ா ் அ�ிகாாிகேகா, ெநைி ைை  ெபிவ்கேகா எவம 
ச�ம�� ே�ைபயிதைல எி்�ைவ�� நாி நி  அைிேபி. எிைவப்றைிய 
பிபரமகைள�� அைியாள ை��� ச ி பட�� �த தலாமத இிைா� 
�ரப்ிவ்க  ெபளியி   யாம எி்�ைவ�� நாி அைிேபி. இ� ி�பி  
பைியாக ப்� எஇ�  மகைள�� ெபளியி்ப�ற  நாி �ைியாக ்கக 
மா ேிி எவ ��ி அளிககிேைி.\ 
 �ிஇல� இ� ி�பித ்மேகறகம�, ி�பித ெச�யப்்� 
அ�ைபசிகிசைசக � ெமவமிி ச�ம�� அளிககிேைி. 
 
 
ேமற்ைிய யாம� எவக  நி  ்ாி�� எவம �ா�ெமாைியித எவக  
எ் மைரககப் ிம. 
ேநர�:  
நா் :  
 ி� : ேசல� 
ேநாயாளியி  ைகெயாப்�  
 
ேநாயாளியி  ெ்யய 
 
 ி�பாளாி  ெ்யய     
         
ி�பாளாி  ைகெயாப்�                                      
     
       
      
 
  
                                                
  
 
 
PATIENT CONSENT FORM 
STUDY TITLE: 
“COMPARATIVE STUDY OF OF  DRAINAGE PROCEDURES IN CHRONIC 
PANCREATITIS., IN GMKMCH, SALEM” 
Department of General surgery, GMKMCH 
PARTICIPANT NAME:   AGE :  SEX:  I.P. NO :
  
 I confirm that I have understood the purpose of surgical/invasive 
procedure for the above study. I have the opportunity to ask the question 
and all my questions and doubts have been answered to my satisfaction. 
I have been explained about the possible complications that may occur 
during and after medical/ surgical procedure. I understand that my 
participation in the study is voluntary and that I am free to withdraw at 
any time without giving any reason. 
I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both  
in respect to the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study. I 
understand that my identity will not be revealed in any information 
released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from the study. 
 
 
I hereby consent to participate in this study for various 
surgical/invasive procedures and their outcomes. 
All of the above was explained to me in my own vernacular language. 
Time : 
Date :  
Place : 
Signature / Thumb Impression Of 
Patient 
 
Patient’s name: 
 
 Signature of the investigator:  
 
Name of the investigator      :     
     
       
 
       
 
 
 
 
 
 
 
  
 
 
KEY TO MASTER CHART 
Sl. No. : Serial Number 
M : Male 
F : Female 
P.I.: Previous Interventions 
B.M.I.: Body Mass Index 
L.S; lumbosacral 
l.v; lateral view 
N.R.A.: No radiological abnormality 
I & D: Incision and Drainage 
E.B.; Excessive bleed 
Min; minutes 
a; easy to perform 
b; mild difficult to perform 
c; difficult to perform 
P.O.B ; Post operative bleeding present 
P.O.P ; Post operative pain present 
Col ; Collection  
E.N ; Wound edge necrosis 
W.I.: Wound Infection 
W.D. : Wound Dehiscence 
W.G; Wound gapping 
  
 
 
Sl.no. NAME AGE SEX OCCUPATION 
CECT ABDOMEN 
TREATMENT 
PE
R 
O
P 
CO
M
PL
IC
AT
IO
N
S 
Du
ra
tio
n 
of
 
Su
rg
er
y 
 
m
in
s 
Ea
se
 o
f 
su
rg
er
y 
PO
ST
O
P 
CO
M
PL
IC
AT
IO
N
S 
  FOLLOE UP 
FREY’S 
PROCEDURE 
PUESTOW 
PROCEDURE 
IZBICKE’S 
PROCEDURE 
DURATION OF 
HOSPITAL STAY 
TIME TAKEN FOR 
COMPLETE 
WOUND 
HEALING 
 
DUCTAL AND 
PARENCHYMAL 
CALCIFICATION 
MAIN PANCREATIC 
DUCT 
CALCIFICATION 
BOTH 
1 RAMESH 25 M Manual labourer PRESENT PRESENT PRESENT +    175 mins B  15 days 11 days  
2 PALANISAMY 42 M Business PRESENT ABSENT ABSENT   + E.B. 160 B P.O.P , W.I 14 days 16 days Recurrence 
3 VEERAPPAN 43 M Manual labourer PRESENT PRESENT PRESENT +  
 
 ADHESION 190 C P.O.P 22days 14 days  
4 ANAND KUMAR 30 M Manual labourer PRESENT PRESENT PRESENT  +   170 B  20days 12 days Recurrence 
5 PERIYANNAN 57 M Manual labourer PRESENT PRESENT PRESENT   +  175 C P.O.P 17 days 14 days  
6 MURUGAN 27 M Business PRESENT ABSENT ABSENT   +  160 A W.I 26days 21days Recurrence 
7 MANIMEGALAI 38 F House wife PRESENT PRESENT PRESENT +    185 A  15 days 12days Recurrence 
8 RAVI 45 M Manual labourer PRESENT PRESENT PRESENT  +   165 A Col, W.I 22days 30days  
9 Muthusamy 45 M Manual labourer PRESENT PRESENT PRESENT  +    170 B W.G 25 days 28days Recurrence 
10 Silambarasan 29 M Manual labourer PRESENT PRESENT PRESENT  +  E.B. 190 C  18 days 20 days  
11 Ramalingam 39 M Manual labourer PRESENT ABSENT ABSENT   +  165 A P.O.P 21days 12days  
12 Ponnumuthu 51 F Manual labourer PRESENT PRESENT PRESENT  +  E.B. 200 C  24 days 12 days Recurrence 
13 Arulmani 28 M Manual labourer PRESENT PRESENT PRESENT  +   160 A  25 days 12 days  
14 Barathy kannan  33 F Business PRESENT ABSENT ABSENT   +  175 B P.O.P 28 days 18 days  
15 Muthu 44 M Manual labourer PRESENT PRESENT PRESENT +   E.B. 185 A W.I 31days 30days Recurrence 
16 Palanivel 41 M Manual labourer PRESENT PRESENT PRESENT   +  185 C  27 days 19 days  
17 Ramalingam 43 M Manual labourer PRESENT PRESENT PRESENT  +   180 A W.G 29 days 33 days  
18 Abuhussain 39 M Clerk PRESENT ABSENT ABSENT   +  170 A  15 days 11days Recurrence 
19 Moorthy 33 M Manual labourer PRESENT PRESENT PRESENT  +   165 A P.O.P 25 days 12 days  
20 Subramani 35 M Manual labourer PRESENT PRESENT PRESENT +    195 C  16 days 62 days  
21 Shivamoorthy 34 M Manual labourer PRESENT PRESENT PRESENT  +   160 A  24 days 12days Recurrence 
22 Venkatesh 31 M Manual labourer PRESENT PRESENT PRESENT +    175 A  22 days 14 days  
23 Subhash 34 M Manual labourer ABSENT PRESENT ABSENT +    180 A  16 days 11days  
24 Tamaraiselvi 36  F  House wife PRESENT PRESENT PRESENT  +   170 C W.I 28 days 23 days Recurrence 
25 Suresh 33 M Manual labourer PRESENT PRESENT PRESENT +    200 C  17 days 18 days  
26 Alagesan 41 M  Business PRESENT ABSENT ABSENT   + E.B. 175 B  19 days 11 days  
27 Arjunan 38 M  Manual labourer PRESENT PRESENT PRESENT +    195 C P.O.P 26days 13 days  
28 Raja 37 M Manual labourer PRESENT PRESENT PRESENT +    180 A W.I 22 days 24days  
29 Vijaykumar 35 M  Manual labourer ABSENT PRESENT ABSENT  +   180 A W.G 25 days 31 days Recurrence 
30 Nausath 34 M  Clerk PRESENT PRESENT PRESENT +    185 B  26 days 11 days  
31 kumaran 32 F Manual labourer PRESENT ABSENT ABSENT   +  165 A P.O.P 31 days 12 days  
32 BABU 43 M  Manual labourer PRESENT PRESENT PRESENT +    170 A  24 days 12 days  
 
 
